ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022 on 1L Axitinib + Pembro in Advanced RCC: Real-World Treatment Outcomes in the United States

106 views
March 2, 2022
0 Comments
Login to view comments. Click here to Login